Literature DB >> 11511175

Detection and characterization of DNA adducts of 3-methylindole.

K A Regal1, G M Laws, C Yuan, G S Yost, G L Skiles.   

Abstract

The pneumotoxin 3-methylindole is metabolized to the reactive intermediate 3-methyleneindolenine which has been shown to form adducts with glutathione and proteins. Reported here is the synthesis, detection, and characterization of nucleoside adducts of 3-methylindole. Adducted nucleoside standards were synthesized by the reaction of indole-3-carbinol with each of the four nucleosides under slightly acidic conditions, which catalyze the dehydration of indole-3-carbinol to 3-methyleneindolenine. Following solid phase extraction, the individual adducts were infused via an electrospray source into an ion trap mass spectrometer for molecular weight determination and characterization of the fragmentation patterns. The molecular ions and fragmentation of the dGuo, dAdo, and dCyd adducts were consistent with nucleophilic addition of the exocyclic primary amine of the nucleosides to the methylene carbon of 3-methyleneindolenine. The apparent chemical preference of this addition lead primarily to dAdo and dGuo adducts, with substantially less of the dCyd adduct formed. No adduct with dThd was detected. The adducts were purified by HPLC and subsequent NMR analysis of the dGuo and dCyd adducts confirmed the proposed structures. Mass spectral fragmentation of the three adducts produced primarily two ions which were the result of the loss of either the 3-methylindole moiety or the sugar. On a triple quadrupole electrospray mass spectrometer, the neutral loss of the sugar, [M + H - 116](+), was utilized for selected reaction monitoring of the calf thymus DNA adducts, formed by incubations of 3-methylindole with various microsomes (rat liver, goat lung, and human liver). All three adducts were detected from each of the microsomal incubations, following extraction and cleavage of the DNA to the nucleoside level. The dGuo adduct was the primary adduct formed, with smaller amounts of the dAdo and dCyd adducts. Rat hepatocytes incubated with 3-methylindole produced the same three adducts, in approximately the same proportions, while no adducts were detected in untreated hepatocytes. Microsomal incubations in the presence of ([3-(2)H(3)]-methyl)indole confirmed the formation and identification of the adducts as well as the fragmentation patterns. These results demonstrate that bioactivated 3-methylindole forms specific adducts with exogenous or intact cellular DNA, and indicates that 3-methylindole may be a potential mutagenic and/or carcinogenic chemical.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511175     DOI: 10.1021/tx0100237

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  10 in total

1.  Improved cytochrome P450 3A4 molecular models accurately predict the Phe215 requirement for raloxifene dehydrogenation selectivity.

Authors:  Chad D Moore; Kiumars Shahrokh; Stephen F Sontum; Thomas E Cheatham; Garold S Yost
Journal:  Biochemistry       Date:  2010-10-19       Impact factor: 3.162

2.  3-Methylindole metabolites induce lung CYP1A1 and CYP2F1 enzymes by AhR and non-AhR mechanisms, respectively.

Authors:  Jessica M Weems; Garold S Yost
Journal:  Chem Res Toxicol       Date:  2010-03-15       Impact factor: 3.739

3.  Chemical and biological mechanisms of phytochemical activation of Nrf2 and importance in disease prevention.

Authors:  Aimee L Eggler; Sergey N Savinov
Journal:  Recent Adv Phytochem       Date:  2013-12-03

4.  Respective roles of CYP2A5 and CYP2F2 in the bioactivation of 3-methylindole in mouse olfactory mucosa and lung: studies using Cyp2a5-null and Cyp2f2-null mouse models.

Authors:  Xin Zhou; Jaime D'Agostino; Lei Li; Chad D Moore; Garold S Yost; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2012-01-06       Impact factor: 3.922

5.  Potent mutagenicity of 3-methylindole requires pulmonary cytochrome P450-mediated bioactivation: a comparison to the prototype cigarette smoke mutagens B(a)P and NNK.

Authors:  Jessica M Weems; John G Lamb; Jaime D'Agostino; Xinxin Ding; Garold S Yost
Journal:  Chem Res Toxicol       Date:  2010-08-26       Impact factor: 3.739

6.  Dehydrogenation of the indoline-containing drug 4-chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide (indapamide) by CYP3A4: correlation with in silico predictions.

Authors:  Hao Sun; Chad Moore; Patrick M Dansette; Santosh Kumar; James R Halpert; Garold S Yost
Journal:  Drug Metab Dispos       Date:  2008-12-12       Impact factor: 3.922

7.  The pneumotoxin 3-methylindole is a substrate and a mechanism-based inactivator of CYP2A13, a human cytochrome P450 enzyme preferentially expressed in the respiratory tract.

Authors:  Jaime D'Agostino; Xiaoliang Zhuo; Mohammad Shadid; Daniel G Morgan; Xiuling Zhang; W Griffith Humphreys; Yue-Zhong Shu; Garold S Yost; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2009-07-16       Impact factor: 3.922

8.  Directed evolution reveals requisite sequence elements in the functional expression of P450 2F1 in Escherichia coli.

Authors:  James B Y H Behrendorff; Chad D Moore; Keon-Hee Kim; Dae-Hwan Kim; Christopher A Smith; Wayne A Johnston; Chul-Ho Yun; Garold S Yost; Elizabeth M J Gillam
Journal:  Chem Res Toxicol       Date:  2012-08-29       Impact factor: 3.739

9.  3-Methylindole is mutagenic and a possible pulmonary carcinogen.

Authors:  Jessica M Weems; Ned S Cutler; Chad Moore; William K Nichols; David Martin; Evan Makin; John G Lamb; Garold S Yost
Journal:  Toxicol Sci       Date:  2009-08-21       Impact factor: 4.849

10.  Single mutations change CYP2F3 from a dehydrogenase of 3-methylindole to an oxygenase.

Authors:  Jaya S Kartha; Konstantine W Skordos; Hao Sun; Clifton Hall; LaHoma M Easterwood; Christopher A Reilly; Eric F Johnson; Garold S Yost
Journal:  Biochemistry       Date:  2008-08-22       Impact factor: 3.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.